Ms. Vita Lanoce joined Linical as CEO of Linical Accelovance Group, in 2018 as a result of the merger. Ms. Lanoce joined Accelovance in 2013 as Sr. Vice President Clinical Operations and in 2016 became Chief Operating Officer. With more than 25 years of experience in the clinical research industry, Ms. Lanoce has a record of building departments, leading organizational change and ensuring achievement of operational excellence by applying high industry standards, policies, systems and processes to an organization. Prior to joining Linical Accelovance Group, Ms. Lanoce had a 15 year tenure with Radiant Development where she held positions of increasing responsibility including Site Director, Director Regional Operations, Director Operations, and Vice President Clinical Operations. Prior to joining Radiant Development, Ms. Lanoce was the Managing Partner and Director of Clinical Operations for two clinical research facilities located in Stuart and Lake Worth, Florida. Ms. Lanoce has held a variety of positions in the biopharmaceutical industry including Clinical Scientist at Bristol-Myers Squibb and Regional Manager for Covance. Ms. Lanoce holds a Master’s of Science in Biomedical Engineering from Rutgers University and a Bachelor of Arts in Biology from Manhattanville College.